July 22, 2025

GoodRx Holdings, Inc. (GDRX): Analyst Consensus and a 32.98% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a key player in the healthcare sector, operates within the Health Information Services industry. With its headquarters in Santa Monica, California, GoodRx is well-known for..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring the 75% Potential Upside

For investors eyeing the healthcare sector, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) presents an intriguing opportunity, particularly with its remarkable potential upside of 75.44%. Specializing in biotechnology, Tarsus is on a..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with a 20% Revenue Growth

Galapagos NV (NASDAQ: GLPG), a Belgian biotechnology company focusing on oncology and immunology, is capturing investor attention with a notable 20.1% revenue growth despite facing challenges typical of the volatile..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 70% Potential Upside with Strong Buy Ratings

In the competitive landscape of the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) stands out within the realm of medical instruments and supplies. With a market capitalization of $1.45 billion, this..

Zai Lab Limited (ZLAB): Analyst Ratings Signal 56% Upside Potential Amid Robust Biotech Portfolio

Investors seeking value in the healthcare sector may find Zai Lab Limited (NASDAQ: ZLAB) an intriguing prospect, as analysts project a substantial 56.84% upside potential for the stock. This China-based..

Rethinking AI for pharmaceutical insight

Investors are discovering that unlocking real-world healthcare insights requires AI engines crafted with domain expertise, not one-size-fits-all models...

PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 34.75% Potential Upside with Innovative Medical Devices

For investors seeking to diversify their portfolios within the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling opportunity, particularly with its robust growth potential and innovative product line..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unpacking a 40% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector with its focus on developing therapies for rare and neurological diseases. With a market capitalization of $2.02 billion,..

Certara, Inc. (CERT) Stock Analysis: Potential 55.60% Upside Lures Investors

Certara, Inc. (NASDAQ: CERT) stands as a significant player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.65 billion, Certara has carved..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 95% Potential Upside

NovoCure Limited (NASDAQ: NVCR) stands at an intriguing juncture, presenting a unique opportunity for investors with a notable potential upside of 95.65%. As a pioneering player in the healthcare sector,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unleashing Nearly 100% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnological innovator headquartered in Durham, North Carolina, is making waves in the healthcare sector, particularly in the niche realm of rare disease therapeutics. With..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech with 140% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has captured the attention of investors with its promising pipeline in the biotechnology sector. With a market capitalization of $2.28 billion, this clinical-stage biotech company..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Through Recent Market Trends

Envista Holdings Corporation (NYSE: NVST), a notable player in the healthcare sector, specializes in developing and marketing dental products across the globe. With a market capitalization of $3.3 billion, Envista..

Haemonetics Corporation (HAE) Stock Analysis: Uncovering a 23% Upside Potential Amidst Strong Buy Ratings

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative suite of hospital technologies. Headquartered in Boston, Massachusetts,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Uncovering a 20.78% Upside Potential in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with its innovative approach to targeting protein growth factors. As a biopharmaceutical company, Scholar Rock is at..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 40% Potential Upside Beckons Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector specializing in medical care facilities, presents an intriguing investment opportunity for those considering the dynamic landscape of non-emergency..

Concentra Group Holdings (CON) Stock Analysis: Exploring a 40% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing opportunity for investors seeking exposure to the..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 41% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, stands out with its robust portfolio of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 32% Potential Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is carving out a significant niche in the dynamic healthcare sector, specifically within the diagnostics and research industry. As a genomics company, GeneDx is at..

Kiniksa Pharmaceuticals (KNSA) Investor Outlook: Eyeing a 43.68% Upside with Strong Buy Ratings

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is generating buzz among investors with its significant growth potential and strong analyst support. Operating in the healthcare sector, specifically within the specialty and generic..

Search

Funds

July 22, 2025

Rethinking AI for pharmaceutical insight

Investors are discovering that unlocking real-world healthcare insights requires AI engines crafted with domain expertise, not one-size-fits-all models...
Search

Funds

July 22, 2025

FTSE 100

Funds